Matthew C. Abramowitz
doctorMale0.0Global Dominance: 0.00%
Dr. Matthew C. Abramowitz is co-chair and clinical lead of the Genitourinary Malignancies Site Disease Group at Sylvester Comprehensive Cancer Center in Miami, Florida, and he emphasized the need for alternatives to the PSA test in light of recent findings about new prostate cancer screening methods.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Matthew C. Abramowitz, M.D., co-chair and clinical lead of the Genitourinary Malignancies Site Disease Group at the Sylvester Comprehensive Cancer Center in Miami, Florida, echoed the need for alternatives to the PSA test.
Experimental prostate cancer test could detect disease better than PSAFox News·
United States· 2025-05-01
United States· 2025-05-01
